Tags

Type your tag names separated by a space and hit enter

Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
Singapore Med J. 2016 Sep; 57(9):476-84.SM

Abstract

Irritable bowel syndrome (IBS) is a common functional bowel disorder. Up to 96% of IBS patients experience bloating, resulting in poor response to conventional therapies and high consultation rates. Many IBS patients report that food triggers symptoms, particularly diets with poorly absorbed, short-chain carbohydrates, and restrict intake of certain foods to control their symptoms. IBS patients are especially susceptible to an attack due to visceral hypersensitivity. An emerging therapeutic strategy excludes fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) from the diet. There is evidence supporting the efficacy of a low FODMAP diet in improving symptoms of bloating in IBS patients. Individualised, structured dietary guidance may benefit those with persistent troublesome symptoms despite traditional therapies. In view of the multifactorial aetiology of the condition, it is probably best to use a multipronged approach, involving combination therapies, to address bloating in IBS patients.

Authors+Show Affiliations

Division of Primary Care, Raffles Medical Group, Singapore. Division of Family Medicine, Department of Medicine, University Medicine Cluster, National University Hospital System, Singapore. Duke-NUS Graduate Medical School, National University of Singapore, Singapore.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

27664186

Citation

Wong, Wei Mon. "Restriction of FODMAP in the Management of Bloating in Irritable Bowel Syndrome." Singapore Medical Journal, vol. 57, no. 9, 2016, pp. 476-84.
Wong WM. Restriction of FODMAP in the management of bloating in irritable bowel syndrome. Singapore Med J. 2016;57(9):476-84.
Wong, W. M. (2016). Restriction of FODMAP in the management of bloating in irritable bowel syndrome. Singapore Medical Journal, 57(9), 476-84. https://doi.org/10.11622/smedj.2016152
Wong WM. Restriction of FODMAP in the Management of Bloating in Irritable Bowel Syndrome. Singapore Med J. 2016;57(9):476-84. PubMed PMID: 27664186.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Restriction of FODMAP in the management of bloating in irritable bowel syndrome. A1 - Wong,Wei Mon, PY - 2016/9/25/entrez PY - 2016/9/25/pubmed PY - 2017/8/5/medline KW - FODMAPs KW - bloating KW - irritable bowel syndrome KW - low FODMAP diet SP - 476 EP - 84 JF - Singapore medical journal JO - Singapore Med J VL - 57 IS - 9 N2 - Irritable bowel syndrome (IBS) is a common functional bowel disorder. Up to 96% of IBS patients experience bloating, resulting in poor response to conventional therapies and high consultation rates. Many IBS patients report that food triggers symptoms, particularly diets with poorly absorbed, short-chain carbohydrates, and restrict intake of certain foods to control their symptoms. IBS patients are especially susceptible to an attack due to visceral hypersensitivity. An emerging therapeutic strategy excludes fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) from the diet. There is evidence supporting the efficacy of a low FODMAP diet in improving symptoms of bloating in IBS patients. Individualised, structured dietary guidance may benefit those with persistent troublesome symptoms despite traditional therapies. In view of the multifactorial aetiology of the condition, it is probably best to use a multipronged approach, involving combination therapies, to address bloating in IBS patients. SN - 0037-5675 UR - https://www.unboundmedicine.com/medline/citation/27664186/Restriction_of_FODMAP_in_the_management_of_bloating_in_irritable_bowel_syndrome_ L2 - http://dx.doi.org/10.11622/smedj.2016152 DB - PRIME DP - Unbound Medicine ER -